000047762 000__ 01080nam\a2200397\i\4500
000047762 001__ 47762
000047762 003__ SzGeWIPO
000047762 005__ 20230503163239.0
000047762 006__ m\\\\eo\\d\\\\\\\\
000047762 007__ cr bn |||m|||a
000047762 008__ 230320s2023\\\\enk\\\\\o\\\\\000\0\eng\d
000047762 035__ $$a(OCoLC)1373642690
000047762 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000047762 041__ $$aeng
000047762 24500 $$aTen things to know about the controversial Humira patent saga.
000047762 264_1 $$a[London, England] :$$bGlobe Business Media Group,$$c2023.
000047762 300__ $$a1 online resource
000047762 336__ $$atext$$2rdacontent
000047762 337__ $$acomputer$$2rdamedia
000047762 338__ $$aonline resource$$bcr$$2rdacarrier
000047762 4901_ $$aIntellectual Asset Management, IAM,$$x1741-1424 ;$$v2023
000047762 542__ $$fhttps://www.iam-media.com/article/ten-things-know-about-the-controversial-humira-patent-saga
000047762 588__ $$aCrossref
000047762 590__ $$aPublished online: 30-Jan-23
000047762 650_0 $$aIntellectual property.
000047762 650_4 $$aIP public policy.
000047762 650_4 $$aBiomedical Research.
000047762 650_4 $$aIntellectual Property Law$$zUnited States of America.
000047762 650_4 $$aPharmaceuticals.
000047762 7001_ $$aHouldsworth, Adam,$$eauthor.
000047762 7731_ $$tIntellectual Asset Management$$wIAM
000047762 830_0 $$aIntellectual Asset Management, IAM,$$x1741-1424 ;$$v2023.
000047762 85641 $$uhttps://www.iam-media.com/article/ten-things-know-about-the-controversial-humira-patent-saga$$yonline version
000047762 904__ $$aArticle
000047762 980__ $$aIAM